CytomX Therapeutics Presents Overview of Conditionally-Activated Antibody-Drug…
- Presentation at World ADC Conference in San Diego - - CX-2051 integrates CytomX core platform expertise to potentially maximize therapeutic window - SOUTH SAN FRANCISCO, Calif., Sept.…